Nebula Research & Development LLC Corcept Therapeutics Inc Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 3,791 shares of CORT stock, worth $258,887. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,791
Previous 11,578
67.26%
Holding current value
$258,887
Previous $583 Million
25.78%
% of portfolio
0.04%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
474Shares Held
83.6MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.13 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$682 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$529 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$420 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$264 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.31B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...